Arturo LoAIza-Bonilla, MD MSEd
@DrBonillaOnc
Followers
5K
Following
181K
Media
2K
Statuses
36K
Co-founder @MassiveBio | Systemwide Hem/Onc Chief at @mystlukes | Using #tech #AI & #genomics to fight cancer at global scale š š š§¬ š„ļø - My Opinion
Metaverse
Joined September 2009
Driving Knowledge to Action: Building a Better Future With Artificial IntelligenceāEnabled Multidisciplinary Oncology | American Society of Clinical Oncology Educational Book
1
2
11
RT @TargetedOnc: WATCH: Arturo Loaiza-Bonilla, MD, MSEd, (@DrBonillaOnc) discusses 5-year data from the phase 3 CheckMate 577 trial, presenā¦.
0
2
0
RT @Larvol: CLDN18.2 Antibody-Drug Conjugate (ADC) Progress in GI Cancers: Pipeline Overview. Explore more about oncology conferences, topā¦.
0
15
0
RT @MatthewCappucci: BREAKING: An incredible "gigantic jet" āĀ an extremely-rare type of upper-atmospheric lightning āĀ was photographed fromā¦.
0
2K
0
RT @rachnatshroff: #ESMOGI25 šØ: Claudin 18.2 bispecific plus nivo/FOLFOX in Claudin 18.2 + #UpperGI cancers!.š points:.- ORR 71%, 6 mth PFSā¦.
0
8
0
RT @TargetedOnc: WATCH: Arturo Loaiza-Bonilla, MD, MSEd, (@DrBonillaOnc) discusses 5-year data from the phase 3 CheckMate 577 trial, presenā¦.
0
1
0
RT @tanayj: Per Wired, Meta is poaching researchers with packages up to $300M over 4 years (with 1st yr comp >$100m), and that they've madeā¦.
0
197
0
RT @TargetedOnc: @DrBonillaOnc discusses the potential of disitamab vedotin, toripalimab, and chemotherapy/trastuzumab in first-line treatmā¦.
0
1
0
RT @MassiveBio: Weāre Massive Bio. We help people with cancer find clinical trials that actually match their caseābased on cancer type, stā¦.
0
1
0
Bemarituzumab Plus Chemotherapy Improved Overall Survival in People With FGFR2b Overexpression GC Compared to Chemotherapy Alone
0
0
1
Everyone: āAI is so smart, we donāt need humans anymore, just vibe prescribing botsā. Models managing real world patients:
0
0
3
Very interesting, NEJM cases are the most costly & complicated, hence published. Key issues comes to practicality: if using the model for decision support increases reimbursement / lowers liability (cost share w model), adoption will skyrocket. Until then, nice benchmarking tool.
Excited to share two advances that bring us closer to real-world impact in healthcare AI:. SDBenchĀ introduces a new benchmark that transforms 304 NEJM cases into interactive diagnostic simulations. AI must ask questions, order tests, and weigh costs, mirroring the complexity of
0
0
1
RT @omooretweets: People are using the ādead grandma trickā to get ChatGPT to give them working Windows 7 activation keys .
0
88
0
RT @LungCancerEu: šØ #Lungcancer survival has more than doubled. New real-world data from France shows 3-year survival for lung adenocarcinā¦.
0
130
0
RT @TargetedOnc: WATCH: Arturo Loaiza-Bonilla, MD, MSEd, (@DrBonillaOnc) discusses findings from the MATTERHORN trial in patients with reseā¦.
0
2
0
RT @VincentRK: .@Costplusdrugs could have had a business model that increased profits and still deliver low cost prescription drugs. Butā¦.
0
36
0
RT @TargetedOnc: @DrBonillaOnc @mystlukes @MassiveBio Thanks for sharing your insights with us at Targeted Onc!.
0
1
0
Breaking Down MATTERHORN: Durvalumab Plus FLOT in Gastric Cancer #ASCO25 ā¦@TargetedOncā© ā¦@mystlukesā© ā¦@MassiveBioā©
1
1
6
Spanish mathematician Javier GĆ³mez Serrano and ā¦@GoogleDeepMindā© ā¦team up to solve the Navier-Stokes million-dollar problem | Science |
0
1
6